Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mireille Snel"'
Autor:
Inès J. Beumer, Marion Persoon, Anke Witteveen, Christa Dreezen, Suet-Feung Chin, Stephen-John Sammut, Mireille Snel, Carlos Caldas, Sabine Linn, Laura J. van 't Veer, Rene Bernards, Annuska M. Glas
Publikováno v:
Biomarker Insights, Vol 2016, Iss 11, Pp 139-146 (2016)
Externí odkaz:
https://doaj.org/article/2e3de5bac305406db4c3434460a6f8e8
Autor:
Hans Wildiers, Cécile Reyes, Sileny Han, Lorenza Mittempergher, Timothé Cynober, F Reyal, Leonie J. M. J. Delahaye, Kevin Punie, Liesbet Vliegen, Ines Nevelsteen, Enora Laas Faron, Laurence Slembrouck, Petra Sintubin, Sara Vander Borght, G Hoste, Patrick Neven, Giuseppe Floris, Audrey Rapinat, Ann Smeets, Sylvain Baulande, Lynn Jongen, Mylène Bohec, Virginie Raynal, David Gentien, Céline Helsmoortel, Mireille Snel, Els Van Nieuwenhuysen, Lauren Darrigues, Isabelle Vanden Bempt, Anke T. Witteveen, Sari Neijenhuis, Cecile Laurent, Annuska M. Glas, Anne Vincent Salomon
Publikováno v:
Translational Oncology, Vol 12, Iss 12, Pp 1557-1565 (2019)
Translational Oncology
Translational Oncology
A previously developed and centrally validated MammaPrint® (MP) and BluePrint® (BP) targeted RNA next-generation sequencing (NGS) kit was implemented and validated in two large academic European hospitals. Additionally, breast cancer molecular subt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b312847395e353c90474276695b5c1
http://www.sciencedirect.com/science/article/pii/S1936523319303511
http://www.sciencedirect.com/science/article/pii/S1936523319303511
Autor:
Mireille Snel, Leonie J. M. J. Delahaye, Anke T. Witteveen, Bob Chan, Lorenza Mittempergher, Christa Dreezen, Naomi Besseling, Ernest Jt Luiten, Sammy Mee
Publikováno v:
Translational Oncology, Vol 13, Iss 4, Pp-(2020)
Translational Oncology
Translational Oncology
The analytical performance of a multi-gene diagnostic signature depends on many parameters, including precision, repeatability, reproducibility and intra-tumor heterogeneity. Here we study the analytical performance of the BluePrint 80-gene breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0dc82e9ede967ab9c681b4707cf9685
http://www.sciencedirect.com/science/article/pii/S1936523319305017
http://www.sciencedirect.com/science/article/pii/S1936523319305017
Autor:
Laura van 't Veer, René Bernards, Anke T. Witteveen, John Zheng, Leonie J. M. J. Delahaye, Bob Chan, Mireille Snel, Guido Brink, Annuska M. Glas, Christa Dreezen, Ines J. Beumer, Sabine C. Linn, Arno Floore, Diederik Wehkamp
Publikováno v:
Breast Cancer Research and Treatment
MammaPrint is an FDA-cleared microarray-based test that uses expression levels of the 70 MammaPrint genes to assess distant recurrence risk in early-stage breast cancer. The prospective RASTER study proved that MammaPrint Low Risk patients can safely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe6a7a654554f9bc3f46ff25be002eb
http://europepmc.org/articles/PMC4819553
http://europepmc.org/articles/PMC4819553
Autor:
Laura J. van't Veer, Annuska M. Glas, Mireille Snel, CA Drukker, René Bernards, Bob Chan, Leonie J. M. J. Delahaye, M. William Audeh, Anke T. Witteveen, Ines J. Beumer, Christa Dreezen
Publikováno v:
Breast cancer research and treatment, 164(2), 461-466. Springer New York
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment
Purpose Early-stage hormone-receptor positive breast cancer is treated with endocrine therapy and the recommended duration of these treatments has increased over time. While endocrine therapy is considered less of a burden to patients compared to che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b93d978f01670ed40fdf0fe4155fc4d
https://pure.amc.nl/en/publications/a-breast-cancer-gene-signature-for-indolent-disease(237ebad8-c79b-4107-a41f-3bd3e0f1f578).html
https://pure.amc.nl/en/publications/a-breast-cancer-gene-signature-for-indolent-disease(237ebad8-c79b-4107-a41f-3bd3e0f1f578).html
Autor:
Paul Roepman, Ian J. Majewski, Gabriel Capellá, Teresa Macarulla, Lodewyk F. A. Wessels, Ramon Salazar, Mireille Snel, Iris Simon, Andreas Schlicker, Josep Tabernero, René Bernards, Victor Moreno, Ulrich Nitsche, George Orphanides, Christine M. Chresta, Sun Tian, Robert D. Rosenberg
Publikováno v:
International Journal of Cancer. Journal International du Cancer
International Journal of Cancer; Vol 134
International Journal of Cancer, 134 (3), 2013
International Journal of Cancer; Vol 134
International Journal of Cancer, 134 (3), 2013
In most colorectal cancer (CRC) patients, outcome cannot be predicted because tumors with similar clinicopathological features can have differences in disease progression and treatment response. Therefore, a better understanding of the CRC biology is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb0e82a6532bb4af9801e1e6a5488dff
https://doi.org/10.1002/ijc.28387
https://doi.org/10.1002/ijc.28387
Autor:
Helmut Friess, Inès Goossens, Eliane Zeestraten, Tibor Schuster, Annuska M. Glas, Gisela Keller, Robert D. Rosenberg, Matthias Maak, Paul Roepman, Mireille Snel, Ulrich Nitsche, Klaus-Peter Janssen, Iris Simon
Publikováno v:
Annals of Surgery. 257:1053-1058
Objectives: The aim of this study was to independently validate a genomic signature developed both to assess recurrence risk in stage II patients and to assist in treatment decisions. Background: Adjuvant therapy is recommended for high-risk patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ec4db98e1d585f2e9521cf30ce7a7e7
https://doi.org/10.1097/sla.0b013e31827c1180
https://doi.org/10.1097/sla.0b013e31827c1180
Autor:
Beilei He, Carlos Caldas, Tycho Bismeijer, Philip C. Schouten, Caroline Lecerf, Oscar M. Rueda, Daniel J. Vis, Elena Provenzano, Cyril H. Benes, René Bernards, Suet-Feung Chin, Finbarr Tarrant, Zheng Xue, A. Barbet, Elaine W. Kay, Lorenza Mittempergher, Mireille Snel, William M. Gallagher, Alexander Gaber, Leanne De Koning, Ultan McDermott, Astrid Bosma, Jelle Wesseling, Stephen John Sammut, Floriane Bard, Ali Hr, Mathew J. Garnett, Bernard Pereira, J. Peeters, Lodewyk F. A. Wessels, Jeroen Heijmans, Andreas Schlicker, Thierry Dubois, Iris Simon, Helen Bardwell, Sabine C. Linn, Karin Jirström, Gillian O'Hurley, Tesa M. Severson, Magali Michaut, Yue Fan, Roelof J.C. Kluin, Sophie Lehn, Ian J. Majewski, Darran P. O'Connor, Jettie J.F. Muris
Publikováno v:
Scientific Reports, 6. Nature Publishing Group
Scientific Reports, 6
Scientific Reports
Scientific Reports, 6
Scientific Reports
Invasive lobular carcinoma (ILC) is the second most frequently occurring histological breast cancer subtype after invasive ductal carcinoma (IDC), accounting for around 10% of all breast cancers. The molecular processes that drive the development of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32249aeaa27bb9f2f8a155d5d396f001
https://dspace.library.uu.nl/handle/1874/346507
https://dspace.library.uu.nl/handle/1874/346507
Autor:
Sara Lonardi, Ulrich Keilholz, René Bernards, Fotios Loupakis, Loredana Vecchione, Antonia Martinetti, Antonio Mulero-Sánchez, Chiara Cremolini, Ines J. Beumer, Matteo Fassan, Filippo Pietrantonio, Gabriella Fontanini, Mireille Snel, Giovanni Fucà, Marta Schirripa, Roberto Moretto
Publikováno v:
Cancer Research. 78:1823-1823
Background BRAF(V600E) colon cancers (CCs) are characterized by a distinct gene expression profile when compared to KRAS mutant and KRAS-BRAF double wild type (WT2) CCs. Most importantly, 20% of WT2 CCs are BRAF-like by gene expression profile (1,2).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47974a6ea43955da12e5eac82e6e83bf
https://doi.org/10.1158/1538-7445.am2018-1823
https://doi.org/10.1158/1538-7445.am2018-1823
Autor:
Boudewijn J.M. Braakhuis, Charles R. Leemans, Olaf H. Temmink, Manon Ceelen, Jacqueline Cloos, Mireille Snel
Publikováno v:
Environmental and Molecular Mutagenesis, 40(2), 79-84. Wiley-Liss Inc.
Cloos, J, Temmink, O, Ceelen, M, Snel, M H J, Leemans, C R & Braakhuis, B J M 2002, ' Involvement of cell cycle control in bleomycin-induced mutagen sensitivity ', Environmental and Molecular Mutagenesis, vol. 40, no. 2, pp. 79-84 . https://doi.org/10.1002/em.10093
Cloos, J, Temmink, O, Ceelen, M, Snel, M H J, Leemans, C R & Braakhuis, B J M 2002, ' Involvement of cell cycle control in bleomycin-induced mutagen sensitivity ', Environmental and Molecular Mutagenesis, vol. 40, no. 2, pp. 79-84 . https://doi.org/10.1002/em.10093
Bleomycin-induced chromosomal instability, generally referred to as mutagen sensitivity, is associated with an increased risk for the development of environmentally related cancer including head and neck squamous cell carcinoma and lung cancer. On av
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e66ac5934360d2ccf2c8f0bcbad08f
http://www.scopus.com/inward/record.url?scp=0036041975&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=0036041975&partnerID=8YFLogxK